Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;14(Suppl 1):S31-4.
doi: 10.4103/0972-2327.83099.

Guidelines for the use of botulinum toxin in movement disorders and spasticity

Afshan Jabeen  1 , Rukmini M Kandadai, Meena A Kannikannan, Rupam Borgohain
Affiliations

Guidelines for the use of botulinum toxin in movement disorders and spasticity

Afshan Jabeen et al. Ann Indian Acad Neurol. 2011 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by

References

    1. Simpson LL. Identification of the major steps in Botulinum toxin action. Ann Rev Pharmacol Toxicol. 2004;44:167–93. - PubMed
    1. Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Messina C. Unilateral injection of botulinum toxin in blepharospam: Single fiber electromyography and blink reflex study. Mov Disord. 1996;11:27–31. - PubMed
    1. Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study. Neurology. 1987;37:616–23. - PubMed
    1. Nussgens Z, Roggenkamper P. Comparison of two Botulinum-toxin preparations in the treatment of essential blepharospasm. Gracfes Arch Clin Exp Ophthalmol. 1997;235:197–9. - PubMed
    1. Sampaio C, Ferreira JJ, Simões F, Rosas MJ, Magalhães M, Correia AP, et al. DYSBOT: A single-blind, randomized parallel study to determine w4hether any differences can be detected in the efficacay and tolerability of two formulations of botulinum toxin type A-Dysport and Botox - assuming a ratio of 4:1. Mov Disord. 1997;12:1013–8. - PubMed